1 |
Nilsson IM. Heredity in hemophilia. In : Berntorp E, editor. Hemophilia. 2nd ed. Stockholm:Octapharma, 2004:19-24
|
2 |
Korea Hemophilia Foundation. Annual report 2005. Seoul : KHF, 2005:23-37
|
3 |
Kim GY. Clinical practice of hemostasis and thrombosis. Seoul : Koonja, 1997:67-87
|
4 |
Keeney S, Mitchell M, Goodeve A. The molecular analysis of haemophilia A : a guideline from the UK haemophilia centre doctor's organization haemophilia genetics laboratory network. Haemophilia 2005;11:387-97
DOI
ScienceOn
|
5 |
O'Donnell J, Tuddenham EGD, Manning R, Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated facotor VIII levels in patients referred for thrombophilia screening : role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997;77:825-8
|
6 |
Pool GP, Hershgold EJ, Pappenhagen AR. High-potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate. Nature 1964;203:312
|
7 |
Kaufman RJ, Antonarakis SE. Structure, biology, and genetics of factor VIII. In : Hoffman R, Benz E, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al., editors. Hematology basic principles and practice. 4th ed. Philadelphia : Elsevier churchill livingstone, 2005:2011-30
|
8 |
Lozier JN, Kessler CM. Clinical aspects and therapy of hemophilia. In : Hoffman R, Benz E, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al., editors. Hematology basic principles and practice. 4th ed. Philadelphia : Elsevier churchill livingstone, 2005:2047-65
|
9 |
Rickard KA. The diagnosis of hemophilia A and B and von Willebrand's disease. In : Forbes CD, Aledort L, Madhok R, editors. Hemophilia. Oxford : Chapman & Hall Medical, 1997:54-62
|
10 |
Rosner F. Hemophilia in the Talmud and rabbinic writings. Ann Intern Med 1969;70:833-7
DOI
ScienceOn
|
11 |
Fijnvandraat K, Bril WS, Voorberg J. Immunology of inhibitor development in hemophilia A. Semin Thromb Haemost 2003;29:69-75
DOI
ScienceOn
|
12 |
Berntorp E. Factor VIII concentrate. In : Forbes CD, Aledort L, Madhok R, editors. Hemophilia. Oxford : Chapman & Hall Medical, 1997:181-92
|
13 |
Korea Hemophilia Foundation. Annual report 2005. Seoul : KHF, 2005:23-37
|
14 |
Roosendaal G, Van den Berg HM, Lafeber FPJG, Bijlsma JWJ. Blood-induced joint damage : an overview of musculoskeletal research in haemophilia. In : Rodriguez-merchan EC, Goddard NJ, Lee CA, editors. Musculoskeletal aspects of haemophilia. Malden:Blackwell Science, 2000:18-26
|
15 |
Kaufman RJ, Antonarakis SE. Structure, biology, and genetics of factor VIII. In : Hoffman R, Benz E, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al., editors. Hematology basic principles and practice. 4th ed. Philadelphia : Elsevier churchill livingstone, 2005:2011-30
|
16 |
Goodeve AC, Peake IR. Diagnosis of hemophilia A and B carriers and prenatal diagnosis. In : Forbes CD, Aledort L, Madhok R, editors. Hemophilia. Oxford : Chapman & Hall Medical, 1997:63-74
|
17 |
Madhok R. Musculoskeletal bleeding in hemophilia. In : Forbes CD, Aledort L, Madhok R, editors. Hemophilia. Oxford : Chapman & Hall Medical, 1997:115-22
|
18 |
Morrissey JH. Tissue factor an factor VII initiation of coagulation. In : Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, editors. Hemostasis and thrombosis. 4th ed. Philadelphia : Linppincott Williams & Wilkins, 2001:89-101
|
19 |
Foster PR, Cuthbertson B, McIntosh RV, MacLeod AJ. Safer clotting factor concentrates. In : Forbes CD, Aledort L, Madhok R, editors. Hemophilia. Oxford : Chapman & Hall Medical, 1997:307-32
|
20 |
Starr D. Blood history. Seoul : Erum Publishing, 1998:67- 101
|
21 |
Yi KN, Rhee CS. Clinical pathology file. 2nd ed. Seoul : Euihak Munwhasa Co. 1993:785-878
|
22 |
Lazarchick J, Hoyer LW. Immunoradiometric measurement of factor VIII procoagulant antigen. J Clin Invest 1978;62: 1048-52
DOI
|